Australia appears to be gain access to innovative treatment for excess weight: Retatrutide. This new dual compound – working on both GLP-1 and GIP receptors – shows remarkable results in international trials, pointing to substantial reductions in weight. While approval is pending with TGA, several people struggling obesity might considering Ret